Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
Frontage Holdings (1521 HK)
Watchlist
62
Analysis
Health Care
•
China
Frontage Holdings Corporation operates as a biotechnology company. The Company offers clinical trials, bioequivalence studies, medical writing, and agrochemical services. Frontage Holdings serves customers in Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Pharmaron Beijing
•
29 Aug 2019 12:55
Pharmaron Beijing IPO Initiation: Clinically Sound
Pharmaron Beijing Co., Ltd. (A) (300759 CH) is a global contract research organisation (CRO) and is one of the top three drug discovery service...
Arun George
Follow
610 Views
Share
bullish
•
Hansoh Pharmaceutical Group
•
05 Aug 2019 03:11
HK IPO Analytics 1H2019: MS and CICC Stand Out
At the beginning of this year, we at Aequitas Research wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...
Ke Yan, CFA, FRM
Follow
696 Views
Share
bullish
•
Hansoh Pharmaceutical Group
•
25 Jul 2019 07:56
HK IPO Analytics 1H2019: Healthcare and Consumer Discretionary Stand Out
At the beginning of this year, we at Aequitas Research wrote on IPO analytics of deals across Asia-Pacific from 2016 to 2018. If you have not read...
Ke Yan, CFA, FRM
Follow
633 Views
Share
bearish
•
Budweiser Brewing APAC
•
04 Jul 2019 00:15
Last Week in GER Research: Budweiser, CIMC, Jinxin Fertility, 360 Finance, Zhongliang, and AMTD
Below is a recap of the key IPO and placement research produced by the Global Equity Research team. This week we update on the IPO valuation for...
Rickin Thakrar
Follow
531 Views
Share
bullish
•
Hangzhou Tigermed Consulting (A)
•
02 Jul 2019 01:29
Shanghai/Shenzhen Connect Ideas: Healthcare Inflows Offset by Financials (2019-06-28)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
Ke Yan, CFA, FRM
Follow
537 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x